Ensuring UK patients benefit from the latest medical innovations
UK patients are missing out on groundbreaking health technologies that offer less invasive treatment options, reduced post-operative pain and faster recovery. This is due to strict regulations and economic challenges. While countries like the United States continue to benefit from these new treatments, UK patients face delays in accessing these advancements.
Mike Branagan-Harris, The HealthTech Strategist, is dedicated to changing this, by lobbying governments for faster regulatory and reimbursement pathways. The goal - ensuring new treatments reach patients sooner.
The NHS has long benefited from US-led innovations like keyhole surgery and cardiovascular therapies, enabling more day-case treatments and reducing
hospital stays.
Through partnerships with MedTech Innovator Programme and Advamed in the US, Mike works directly with innovators to encourage them to bring cutting-edge medical technologies to the UK.
At The HealthTech Strategist, Mike continues to push for the UK to embrace lifechanging medical advancements. With the NHS facing growing waitlists, now is the time to act.
If you're involved in medical technology or healthcare policy and want to help get transformative technologies to patients faster, get in touch today.
Book your free 1-hour consultation today and confidently navigate your entry to the UK market.
